Paper Details 
Original Abstract of the Article :
Ten extended spectrum beta-lactamases producing strains of Klebsiella pneumoniae characterized by analytical isoelectric focusing and studied for their susceptibility to beta-lactam antibiotics, either alone or in combination with a beta-lactamase inhibitor (clavulanic acid and sulbactam) and in ass...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/jac/36.1.241

データ提供:米国国立医学図書館(NLM)

Fighting Beta-Lactamase Producing Klebsiella Pneumoniae: A Battle in the Desert of Antibiotic Resistance

This research delves into the challenging world of antibiotic resistance, focusing on the emergence of extended-spectrum beta-lactamases (ESBLs) producing *Klebsiella pneumoniae*. The study examines the bactericidal effects of various antibiotics, including beta-lactams and amikacin, against ESBL-producing *K. pneumoniae*. The researchers found that combinations of cefotaxime plus co-amoxiclav with or without amikacin exhibited strong bactericidal activity, offering potential therapeutic options for infections caused by ESBL-producing *K. pneumoniae*.

Navigating the Shifting Sands of Antibiotic Resistance

This research highlights the critical challenge of antibiotic resistance, focusing on the emergence of ESBLs producing *K. pneumoniae*. The study's findings provide valuable insights into the potential therapeutic options for infections caused by these resistant bacteria, offering hope in the ongoing battle against antibiotic resistance. This journey through the desert of antibiotic resistance requires a multidisciplinary approach, combining clinical expertise, research, and public health initiatives to address this pressing global health concern.

The Importance of Combating Antibiotic Resistance

This research underscores the importance of combating antibiotic resistance, a growing threat to global health. The study's findings highlight the need for continuous research and development of new antibiotics and therapeutic strategies to effectively address infections caused by resistant bacteria. This journey through the desert of antibiotic resistance requires a collaborative effort between scientists, clinicians, and public health officials to protect human health and prevent the spread of resistant infections.

Dr. Camel's Conclusion

This research highlights the critical challenge of antibiotic resistance, focusing on the emergence of ESBLs producing *K. pneumoniae*. The study's findings provide valuable insights into potential therapeutic options for infections caused by these resistant bacteria, offering hope in the ongoing battle against antibiotic resistance. This journey through the desert of antibiotic resistance requires a multidisciplinary approach, combining clinical expertise, research, and public health initiatives to address this pressing global health concern.
Date :
  1. Date Completed 1996-02-06
  2. Date Revised 2019-05-12
Further Info :

Pubmed ID

8537274

DOI: Digital Object Identifier

10.1093/jac/36.1.241

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.